Review challenges in the use of normality testing situations and recommendations on how to assess data distributions in the pharmaceutical development manufacturing environment
Kim Erland Vukovinsky
Advertisement
Articles by Kim Erland Vukovinsky
The authors describe a modified version of the Large-N test used to determine content uniformity.
Advertisement
Latest Updated Articles
A Proposed Content-Uniformity Test for Large Sample SizesPublished: November 2nd 2010 | Updated:
The Role of Normal Data Distribution in Pharmaceutical Development and ManufacturingPublished: October 2nd 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
5
